Study of curative effect of combined therapy in the elderly patients with oral squamous-cell carcinoma / 中华老年医学杂志

0.05).There was significant difference in the 3-year survival rate between A and C group. Conclusions The 3-year survival rate was dramatically increased with combined therapy mainly by cisplatin, the dose of 60～80mg is tolerant for the elderly aged above seventy years, and perioperation complications can be cured.